Cargando…
Bioreactor Technologies for Enhanced Organoid Culture
An organoid is a 3D organization of cells that can recapitulate some of the structure and function of native tissue. Recent work has seen organoids gain prominence as a valuable model for studying tissue development, drug discovery, and potential clinical applications. The requirements for the succe...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380004/ https://www.ncbi.nlm.nih.gov/pubmed/37511186 http://dx.doi.org/10.3390/ijms241411427 |
_version_ | 1785080103701577728 |
---|---|
author | Licata, Joseph P. Schwab, Kyle H. Har-el, Yah-el Gerstenhaber, Jonathan A. Lelkes, Peter I. |
author_facet | Licata, Joseph P. Schwab, Kyle H. Har-el, Yah-el Gerstenhaber, Jonathan A. Lelkes, Peter I. |
author_sort | Licata, Joseph P. |
collection | PubMed |
description | An organoid is a 3D organization of cells that can recapitulate some of the structure and function of native tissue. Recent work has seen organoids gain prominence as a valuable model for studying tissue development, drug discovery, and potential clinical applications. The requirements for the successful culture of organoids in vitro differ significantly from those of traditional monolayer cell cultures. The generation and maturation of high-fidelity organoids entails developing and optimizing environmental conditions to provide the optimal cues for growth and 3D maturation, such as oxygenation, mechanical and fluidic activation, nutrition gradients, etc. To this end, we discuss the four main categories of bioreactors used for organoid culture: stirred bioreactors (SBR), microfluidic bioreactors (MFB), rotating wall vessels (RWV), and electrically stimulating (ES) bioreactors. We aim to lay out the state-of-the-art of both commercial and in-house developed bioreactor systems, their benefits to the culture of organoids derived from various cells and tissues, and the limitations of bioreactor technology, including sterilization, accessibility, and suitability and ease of use for long-term culture. Finally, we discuss future directions for improvements to existing bioreactor technology and how they may be used to enhance organoid culture for specific applications. |
format | Online Article Text |
id | pubmed-10380004 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103800042023-07-29 Bioreactor Technologies for Enhanced Organoid Culture Licata, Joseph P. Schwab, Kyle H. Har-el, Yah-el Gerstenhaber, Jonathan A. Lelkes, Peter I. Int J Mol Sci Review An organoid is a 3D organization of cells that can recapitulate some of the structure and function of native tissue. Recent work has seen organoids gain prominence as a valuable model for studying tissue development, drug discovery, and potential clinical applications. The requirements for the successful culture of organoids in vitro differ significantly from those of traditional monolayer cell cultures. The generation and maturation of high-fidelity organoids entails developing and optimizing environmental conditions to provide the optimal cues for growth and 3D maturation, such as oxygenation, mechanical and fluidic activation, nutrition gradients, etc. To this end, we discuss the four main categories of bioreactors used for organoid culture: stirred bioreactors (SBR), microfluidic bioreactors (MFB), rotating wall vessels (RWV), and electrically stimulating (ES) bioreactors. We aim to lay out the state-of-the-art of both commercial and in-house developed bioreactor systems, their benefits to the culture of organoids derived from various cells and tissues, and the limitations of bioreactor technology, including sterilization, accessibility, and suitability and ease of use for long-term culture. Finally, we discuss future directions for improvements to existing bioreactor technology and how they may be used to enhance organoid culture for specific applications. MDPI 2023-07-13 /pmc/articles/PMC10380004/ /pubmed/37511186 http://dx.doi.org/10.3390/ijms241411427 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Licata, Joseph P. Schwab, Kyle H. Har-el, Yah-el Gerstenhaber, Jonathan A. Lelkes, Peter I. Bioreactor Technologies for Enhanced Organoid Culture |
title | Bioreactor Technologies for Enhanced Organoid Culture |
title_full | Bioreactor Technologies for Enhanced Organoid Culture |
title_fullStr | Bioreactor Technologies for Enhanced Organoid Culture |
title_full_unstemmed | Bioreactor Technologies for Enhanced Organoid Culture |
title_short | Bioreactor Technologies for Enhanced Organoid Culture |
title_sort | bioreactor technologies for enhanced organoid culture |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380004/ https://www.ncbi.nlm.nih.gov/pubmed/37511186 http://dx.doi.org/10.3390/ijms241411427 |
work_keys_str_mv | AT licatajosephp bioreactortechnologiesforenhancedorganoidculture AT schwabkyleh bioreactortechnologiesforenhancedorganoidculture AT harelyahel bioreactortechnologiesforenhancedorganoidculture AT gerstenhaberjonathana bioreactortechnologiesforenhancedorganoidculture AT lelkespeteri bioreactortechnologiesforenhancedorganoidculture |